Diabetes Metabolic Syndrome and Obesity-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2234732, encodeId=d8682234e32dd, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从开始投稿到见刊共耗时五个月左右，中间大修过一次，有两个审稿人的意见，总体来说意见都挺诚恳的，照着一条一条修改就行，总体还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8445702010, createdName=ms8000000933790308, createdTime=Sat Nov 02 11:45:54 CST 2024, time=2024-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248876, encodeId=32a722488e660, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志还是SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593c2431229, createdName=123b8046m75暂无昵称, createdTime=Mon Jan 20 12:50:25 CST 2025, time=2025-01-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2218605, encodeId=eb29221860527, content=请问各位大佬，1DA持续10天了正常吗<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Aug 05 15:47:57 CST 2024, time=2024-08-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2201651, encodeId=902022016513b, content=审稿速度:2.0 偏重的研究方向：糖尿病心肌病 经验分享：4b以后多久有下一步呀，需要等几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5f9177451, createdName=ms4000000458879756, createdTime=Fri May 03 23:54:18 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194334, encodeId=0f382194334cc, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 17:49:23 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆)]

2024-11-02 ms8000000933790308 来自浙江省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：糖尿病
经验分享：从开始投稿到见刊共耗时五个月左右，中间大修过一次，有两个审稿人的意见，总体来说意见都挺诚恳的，照着一条一条修改就行，总体还算友好

31 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234732, encodeId=d8682234e32dd, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从开始投稿到见刊共耗时五个月左右，中间大修过一次，有两个审稿人的意见，总体来说意见都挺诚恳的，照着一条一条修改就行，总体还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8445702010, createdName=ms8000000933790308, createdTime=Sat Nov 02 11:45:54 CST 2024, time=2024-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248876, encodeId=32a722488e660, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志还是SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593c2431229, createdName=123b8046m75暂无昵称, createdTime=Mon Jan 20 12:50:25 CST 2025, time=2025-01-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2218605, encodeId=eb29221860527, content=请问各位大佬，1DA持续10天了正常吗<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Aug 05 15:47:57 CST 2024, time=2024-08-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2201651, encodeId=902022016513b, content=审稿速度:2.0 偏重的研究方向：糖尿病心肌病 经验分享：4b以后多久有下一步呀，需要等几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5f9177451, createdName=ms4000000458879756, createdTime=Fri May 03 23:54:18 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194334, encodeId=0f382194334cc, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 17:49:23 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆)]

2025-01-20 123b8046m75暂无昵称来自广西

审稿速度:6.0 | 投稿命中率:50.0
经验分享：这个杂志还是SCI吗

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2234732, encodeId=d8682234e32dd, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从开始投稿到见刊共耗时五个月左右，中间大修过一次，有两个审稿人的意见，总体来说意见都挺诚恳的，照着一条一条修改就行，总体还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8445702010, createdName=ms8000000933790308, createdTime=Sat Nov 02 11:45:54 CST 2024, time=2024-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248876, encodeId=32a722488e660, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志还是SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593c2431229, createdName=123b8046m75暂无昵称, createdTime=Mon Jan 20 12:50:25 CST 2025, time=2025-01-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2218605, encodeId=eb29221860527, content=请问各位大佬，1DA持续10天了正常吗<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Aug 05 15:47:57 CST 2024, time=2024-08-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2201651, encodeId=902022016513b, content=审稿速度:2.0 偏重的研究方向：糖尿病心肌病 经验分享：4b以后多久有下一步呀，需要等几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5f9177451, createdName=ms4000000458879756, createdTime=Fri May 03 23:54:18 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194334, encodeId=0f382194334cc, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 17:49:23 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆)]

2022-04-26 ms6000001781488545

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：糖尿病
经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。

105 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234732, encodeId=d8682234e32dd, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从开始投稿到见刊共耗时五个月左右，中间大修过一次，有两个审稿人的意见，总体来说意见都挺诚恳的，照着一条一条修改就行，总体还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8445702010, createdName=ms8000000933790308, createdTime=Sat Nov 02 11:45:54 CST 2024, time=2024-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248876, encodeId=32a722488e660, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志还是SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593c2431229, createdName=123b8046m75暂无昵称, createdTime=Mon Jan 20 12:50:25 CST 2025, time=2025-01-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2218605, encodeId=eb29221860527, content=请问各位大佬，1DA持续10天了正常吗<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Aug 05 15:47:57 CST 2024, time=2024-08-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2201651, encodeId=902022016513b, content=审稿速度:2.0 偏重的研究方向：糖尿病心肌病 经验分享：4b以后多久有下一步呀，需要等几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5f9177451, createdName=ms4000000458879756, createdTime=Fri May 03 23:54:18 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194334, encodeId=0f382194334cc, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 17:49:23 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆)]

2024-08-05 ms6000000357694689 来自北京

请问各位大佬，1DA持续10天了正常吗#期刊论坛#

98 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234732, encodeId=d8682234e32dd, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从开始投稿到见刊共耗时五个月左右，中间大修过一次，有两个审稿人的意见，总体来说意见都挺诚恳的，照着一条一条修改就行，总体还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8445702010, createdName=ms8000000933790308, createdTime=Sat Nov 02 11:45:54 CST 2024, time=2024-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248876, encodeId=32a722488e660, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志还是SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593c2431229, createdName=123b8046m75暂无昵称, createdTime=Mon Jan 20 12:50:25 CST 2025, time=2025-01-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2218605, encodeId=eb29221860527, content=请问各位大佬，1DA持续10天了正常吗<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Aug 05 15:47:57 CST 2024, time=2024-08-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2201651, encodeId=902022016513b, content=审稿速度:2.0 偏重的研究方向：糖尿病心肌病 经验分享：4b以后多久有下一步呀，需要等几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5f9177451, createdName=ms4000000458879756, createdTime=Fri May 03 23:54:18 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194334, encodeId=0f382194334cc, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 17:49:23 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆)]

2023-02-26 ms3000000909608469 来自山西省

1a状态一周了还没有变，需要给编辑写信催一下吗

117 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234732, encodeId=d8682234e32dd, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从开始投稿到见刊共耗时五个月左右，中间大修过一次，有两个审稿人的意见，总体来说意见都挺诚恳的，照着一条一条修改就行，总体还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8445702010, createdName=ms8000000933790308, createdTime=Sat Nov 02 11:45:54 CST 2024, time=2024-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248876, encodeId=32a722488e660, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志还是SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593c2431229, createdName=123b8046m75暂无昵称, createdTime=Mon Jan 20 12:50:25 CST 2025, time=2025-01-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2218605, encodeId=eb29221860527, content=请问各位大佬，1DA持续10天了正常吗<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Aug 05 15:47:57 CST 2024, time=2024-08-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2201651, encodeId=902022016513b, content=审稿速度:2.0 偏重的研究方向：糖尿病心肌病 经验分享：4b以后多久有下一步呀，需要等几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5f9177451, createdName=ms4000000458879756, createdTime=Fri May 03 23:54:18 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194334, encodeId=0f382194334cc, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 17:49:23 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆)]

2024-05-03 ms4000000458879756 来自河北省

审稿速度:2.0
偏重的研究方向：糖尿病心肌病
经验分享：4b以后多久有下一步呀，需要等几天呀

103 0

[GetPortalCommentsPageByObjectIdResponse(id=2234732, encodeId=d8682234e32dd, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从开始投稿到见刊共耗时五个月左右，中间大修过一次，有两个审稿人的意见，总体来说意见都挺诚恳的，照着一条一条修改就行，总体还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8445702010, createdName=ms8000000933790308, createdTime=Sat Nov 02 11:45:54 CST 2024, time=2024-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248876, encodeId=32a722488e660, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志还是SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593c2431229, createdName=123b8046m75暂无昵称, createdTime=Mon Jan 20 12:50:25 CST 2025, time=2025-01-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2218605, encodeId=eb29221860527, content=请问各位大佬，1DA持续10天了正常吗<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Aug 05 15:47:57 CST 2024, time=2024-08-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2201651, encodeId=902022016513b, content=审稿速度:2.0 偏重的研究方向：糖尿病心肌病 经验分享：4b以后多久有下一步呀，需要等几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5f9177451, createdName=ms4000000458879756, createdTime=Fri May 03 23:54:18 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194334, encodeId=0f382194334cc, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 17:49:23 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆)]

2023-04-09 ms5000001014125810 来自新疆

审稿速度:1.0
偏重的研究方向：糖尿病
经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？

146 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234732, encodeId=d8682234e32dd, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从开始投稿到见刊共耗时五个月左右，中间大修过一次，有两个审稿人的意见，总体来说意见都挺诚恳的，照着一条一条修改就行，总体还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8445702010, createdName=ms8000000933790308, createdTime=Sat Nov 02 11:45:54 CST 2024, time=2024-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248876, encodeId=32a722488e660, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志还是SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593c2431229, createdName=123b8046m75暂无昵称, createdTime=Mon Jan 20 12:50:25 CST 2025, time=2025-01-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2218605, encodeId=eb29221860527, content=请问各位大佬，1DA持续10天了正常吗<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Aug 05 15:47:57 CST 2024, time=2024-08-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2201651, encodeId=902022016513b, content=审稿速度:2.0 偏重的研究方向：糖尿病心肌病 经验分享：4b以后多久有下一步呀，需要等几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5f9177451, createdName=ms4000000458879756, createdTime=Fri May 03 23:54:18 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194334, encodeId=0f382194334cc, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 17:49:23 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆)]

2024-03-08 ms8000001966358118 来自安徽省

1A 10天了，这个状态正常吗，需要催一下编辑吗？

121 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234732, encodeId=d8682234e32dd, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从开始投稿到见刊共耗时五个月左右，中间大修过一次，有两个审稿人的意见，总体来说意见都挺诚恳的，照着一条一条修改就行，总体还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8445702010, createdName=ms8000000933790308, createdTime=Sat Nov 02 11:45:54 CST 2024, time=2024-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248876, encodeId=32a722488e660, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志还是SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593c2431229, createdName=123b8046m75暂无昵称, createdTime=Mon Jan 20 12:50:25 CST 2025, time=2025-01-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2218605, encodeId=eb29221860527, content=请问各位大佬，1DA持续10天了正常吗<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Aug 05 15:47:57 CST 2024, time=2024-08-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2201651, encodeId=902022016513b, content=审稿速度:2.0 偏重的研究方向：糖尿病心肌病 经验分享：4b以后多久有下一步呀，需要等几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5f9177451, createdName=ms4000000458879756, createdTime=Fri May 03 23:54:18 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194334, encodeId=0f382194334cc, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 17:49:23 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆)]

2024-03-20 零零一来自广西

周期也就两三个月

110 0

[GetPortalCommentsPageByObjectIdResponse(id=2234732, encodeId=d8682234e32dd, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从开始投稿到见刊共耗时五个月左右，中间大修过一次，有两个审稿人的意见，总体来说意见都挺诚恳的，照着一条一条修改就行，总体还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8445702010, createdName=ms8000000933790308, createdTime=Sat Nov 02 11:45:54 CST 2024, time=2024-11-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2248876, encodeId=32a722488e660, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这个杂志还是SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593c2431229, createdName=123b8046m75暂无昵称, createdTime=Mon Jan 20 12:50:25 CST 2025, time=2025-01-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1214437, encodeId=0dc3121443ed4, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：从投稿到online三个月左右，研究生的第一篇，版面费有点贵，着急毕业的投这个可以，由于进展比较顺利，总觉得这一万八掏的有点大*种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Tue Apr 26 11:33:38 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2218605, encodeId=eb29221860527, content=请问各位大佬，1DA持续10天了正常吗<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e189183299, createdName=ms6000000357694689, createdTime=Mon Aug 05 15:47:57 CST 2024, time=2024-08-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2201651, encodeId=902022016513b, content=审稿速度:2.0 偏重的研究方向：糖尿病心肌病 经验分享：4b以后多久有下一步呀，需要等几天呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5f9177451, createdName=ms4000000458879756, createdTime=Fri May 03 23:54:18 CST 2024, time=2024-05-03, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194334, encodeId=0f382194334cc, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Wed Mar 20 17:49:23 CST 2024, time=2024-03-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆)]

2023-03-18 ms5000001014125810 来自新疆

偏重的研究方向：临床
经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。

124 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务